Skip to main content
Premium Trial:

Request an Annual Quote

And We Thought the Difference Was Just Taste in Footwear

Over at his BBGM blog, Deepak Singh mulls over the differences between academia and industry. Using his software experience as a foundation, Singh writes that from what he's seen, the major difference comes in process control: While "basic research and early stage discovery can be a lot like academia," he blogs, "research gets a lot more 'locked down' so to speak" in the drug development phase. He notes that software in a clinical setting tends to have far fewer features because it's tough to allow for that kind of complexity in a very controlled, highly regulated environment.


The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.